Privia Health Group, Inc. (PRVA): Price and Financial Metrics

Privia Health Group, Inc. (PRVA): $23.81

0.17 (+0.72%)

POWR Rating

Component Grades













PRVA Stock Price Chart Interactive Chart >

Price chart for PRVA

PRVA Price/Volume Stats

Current price $23.81 52-week high $50.77
Prev. close $23.64 52-week low $17.99
Day low $23.40 Volume 329,258
Day high $24.30 Avg. volume 691,870
50-day MA $24.73 Dividend yield N/A
200-day MA $25.17 Market Cap 2.59B

Privia Health Group, Inc. (PRVA) Company Bio

Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.

PRVA Latest News Stream

Event/Time News Detail
Loading, please wait...

PRVA Latest Social Stream

Loading social stream, please wait...

View Full PRVA Social Stream

Latest PRVA News From Around the Web

Below are the latest news stories about Privia Health Group Inc that investors may wish to consider to help them evaluate PRVA as an investment opportunity.

Privia Health to Participate in SVB Leerink Virtual Healthcare Conference

ARLINGTON, Va., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that the Company’s management team will participate in a virtual fireside chat as part of the SVB Leerink 11th Annual Global Healthcare Conference on Wednesday, February 16, 2022, beginning at 4:20 pm ET. The webcast and replay of the event, as well as the accompanying slide presentation, will be available at About Privia Health Privia

Yahoo | February 15, 2022

Privia and Javara collaborate in Moderna’s vaccine study for respiratory syncytial virus

Privia Health Group <> has partnered with Javara to advance a phase 2/3 study for mRNA-1345, an investigational vaccine candidate developed by Moderna (MRNA) for the…

Seeking Alpha | February 14, 2022

Javara Contributes to RSV Prevention Vaccine Trial in Collaboration with Privia Health and Moderna

Javara, a leading Integrated Research Organization focused on delivering access to clinical trials at the point of care, today announced an opportunity for adults age 60 or older who live in the Fayetteville, Georgia; Annapolis, Maryland; or Fort Worth, Texas areas to participate in a clinical trial of a new investigational vaccine aimed at protecting them from the respiratory syncytial virus (RSV). This clinical trial is being launched in partnership with certain Privia Health Group (Nasdaq: PR

Yahoo | February 14, 2022

An Intrinsic Calculation For Privia Health Group, Inc. (NASDAQ:PRVA) Suggests It's 50% Undervalued

In this article we are going to estimate the intrinsic value of Privia Health Group, Inc. ( NASDAQ:PRVA ) by taking the...

Yahoo | February 7, 2022

Privia Health Group: Not Healthy Yet

No summary available.

Seeking Alpha | February 6, 2022

Read More 'PRVA' Stories Here

PRVA Price Returns

1-mo -2.06%
3-mo -6.19%
6-mo 0.42%
1-year -28.07%
3-year N/A
5-year N/A
YTD -7.96%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7012 seconds.